Fact CheckerSign in

NCT06747364Recruiting

Phosphatidylethanol and Other Ethanol Consumption Markers

Source: ClinicalTrials.gov · Last updated 13 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study is intended to help the investigators understand how a biomarker found in the blood may be used to better identify the quantity and different patterns of alcohol use. The investigators hope that the results of this study will help identify the uses of alcohol-use markers in the blood in future alcohol prevention and treatment programs. It is hoped that the information learned from this study will benefit other people in the future. The study participants will come into the lab and will (1) consume alcohol in the lab designed to produce a peak blood alcohol concentration of 0.06% and have blood collected over 6 hours followed by abstinence for 10 days to give a small blood sample 4 times and (2) to give a small amount of blood 5 times within 28 days (naturalistic drinking) and provide answers about alcohol use.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
80 (estimated)
First submitted
18 Dec 2024
Start date
7 Jan 2025
Primary completion date
Jun 2029
Lead sponsor
The University of Texas Health Science Center at San Antonio
NCT number
NCT06747364

What you commit to

  • Study type: Interventional
  • Planned participants: 80
  • From 7 Jan 2025 to the primary completion date, Jun 2029
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • have substance use disorder (except nicotine, and/or caffeine);
  • have a medical condition that would contraindicate participation (a positive urine pregnancy test, self-reported scheduled surgery or liver disease);
  • have a presence of a DSM-5 psychiatric disorder with symptoms of psychosis and/or delirium; or

Other

  • have significant current or predicted alcohol withdrawal symptoms (CIWA-AR scores ≥ 10);
  • are currently in alcohol treatment;
  • are currently breast feeding;
  • are unable to comprehend the informed consent process or study instructions.

Who the study is looking for

  • are ≥ 21 years old;
  • are height and weight proportionate (body mass index 18-30); and
  • report drinking on \> 1 days in the last month, with at least one day equal to at least achieving \~0.06% BAC.

Age in the registry: 21 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of North Texas
Coordinator of this site? Confirm its status
DentonUnited StatesRecruiting
University of Texas Health Science Center San Antonio
Coordinator of this site? Confirm its status
San AntonioUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.